Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein

Mediators of Inflammation

Volumn 5, Issue 1, 1996, Pages 47-50

  Haggblom J O ^a   Jokilammi Siltanen, A B ^a   Peuravuori, H ^a   Nevalainen, T J ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

BactericidaJ permeabilily increasing protein; ELISA; Polymorphonuclear leukocytes; Serum plasma protein; Time resolved fluoroimmunoassay

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; C REACTIVE PROTEIN; LIPOPOLYSACCHARIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FLUOROIMMUNOASSAY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL;

NEGIBACTERIA; ORYCTOLAGUS CUNICULUS;

EID: 0029924538     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/S0962935196000087     Document Type: Article

References (28)

1. Gray PW, Flaggs G, Leong SR, Gumina RJ, Weiss J, Ooi CE, Elsbach P. Cloning of a human neutrophil bactericidal protein. J Biol Chem 1989; 264: 9505–9509.
2. 2- terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal permeability-increasing protein. J Biol Chem 1987; 262: 14891–14894.
3. Elsbach P, Weiss J. Phagocytosis of bacteria and phospholipid degradation. Biochim Biophys Acta 1988; 947: 29–52.
4. Weiss J, Elsbach P, Shu C, Castillo J, Grinman J, Horwitz A, Theofan G. The human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum resistant gram-negative bacteria. J Clin Invest 1992; 90: 1122–1130.
5. Weiss J, Beckerdite-Quagliata S, Elsbach P. Determinants of the action of phospholipases A2 on the envelope phospholipids of Escherichia coli. J Biol Chem 1979; 254: 11010–11014.
6. Forst S, Weiss J, Maraganoe JM, Heinrikson RL, Elsbach P. Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-increasing protein of neutrophils. Biochem Biophys Acta 1987; 920: 221–225.
7. Wilde CG, Seilhamer JJ, McGrogan M, et al. BactericidaVpermeability-increasing protein and lipopolysaccharide (LPS)-binding protein. J Biol Chem 1994; 269: 17411–17416.
8. Tobias PS, Ulevitch RJ. Lipopolysaccharide-binding-protein (LBP) and CD14 in lipopolysaccharide-dependent macrophage activation. Immuno-biol 1993; 187: 227–232.
9. Haziot A, Tsuberi BZ, Goyert SM. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol 1993; 150: 15556–15565.
10. Ischii Y, Wang Y, Haziot A, Del Vecchio PJ, Goyert SM, Malik AB. Lipopo- lysaccharide-binding-protein and CD14 interaction induces tumor necrosis factor-alpha generation and neutrophil sequestration in lungs after intratracheal endotoxin. Canc Res 1993; 73: 15–23.
11. Heumann D, Gallay P, Betz-Corradin S, Barras C, Baumgartner JD, Glauser MP. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding-protein for binding to monocytes. J Infect Dis 1993; 167: 1351–1357.
12. Dentener WA, van Asmuth EJ, Francot GJ, Marra MN, Buurman WA. Antagonistic effects of lipopolysaccharide-binding-protein and bactericidal/permeability-increasing protein on lipopolysaccharide (LPS) induced cytokine release by mononuclear phagocytes. Competition for binding to LPS. J Immunol 1993; 151: 4258–4265.
13. Ooi CE, Weiss J, Doerfler ME, Elsbach P. Endotoxin neutralizing properties of the 25-kD N-terminal fragment and a newly isolated 30-kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med 1991; 174: 649–655.
14. Marra MN, Thornton MB, Snable JL, Wilde CG, Scott RW. Endotoxin binding and neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5. Crit Care Med 1994; 22: 559–565.
15. Gazzano-Santoro H, Meszaros K, Birr C, et al. rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein and lipopoly- saccharide-binding-protein for binding to lipopolysaccharide and gramnegative bacteria. Infect Immun 1994; 62: 1185–1191.
16. Corradin SB, Heumann D, Gallay P, Smith J, Manel J, Glauser MP. Bactericidal/permeability-increasing protein inhibits induction of macrophage nitric oxide production by lipopolysaccharide. J Infect Dis 1994; 169: 105–111.
17. Ammons WS, Kung AH. Recombinant amino-terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin. Circ Shock 1993; 41: 176–184.
18. Kohn FR, Ammons WS, Horwitz A, Grinman L, Theofan G, Weickmann J, Kung AH. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia. J Infect Dis 1993; 168: 1307–1310.
19. Meszaros K, Parent JB, Gazzano-Santoro H, et al. A recombinant amino- terminal fragment of bactericidaVpermeabÜity-increasing protein inhibits the induction of leucocyte responses to lipopolysaccharide. J Leukoc Biol 1993; 54: 55B–563.
20. Fisher Jr CJ, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM. Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: a placebo-controlled study. Crit Care Med 1994; 22: 553–558.
21. Gazzano-Santoro H, Parent JB, Grinman L, et al. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid-A region of lipopolysaccharide. Infect Immun 1992; 60: 4754–4761.
22. Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992; 148: 532–537.
23. Weiss J, Wright G. Mobilization and function of extracellular phospholipase A2 in inflammation. Adv Exp Med Biol 1990; 275: 103–113.
24. Tobias PS, Soldau K, Ulevitch RJ. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide-binding-protein (LBP). J Biol Chem 1989; 264: 10867–10871.
25. Mathison J, Tobias P, Wolfson E, Ulevitch RJ. Regulatory mechanisms of host responsiveness to endotoxin (lipopolysaccharide). Pathobiology 1991; 59: 185–188.
26. Wilde CG, Seilhamer M, McGrogan N, et al. Bactericidal/permeability- increasing protein and lipopolysaccharide (LPS)-binding protein. J Biol Chem 1994; 269: 17411–17416.
27. Hsu SM, Raine L, Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–580.
28. White ML, Ma JK, Birr CA, Trown PW, Carroll SF. Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA. J Immun Methods 1994; 167: 227–235.